EUROPEAN UROLOGY
Scope & Guideline
Pioneering research in the heart of urology.
Introduction
Aims and Scopes
- Clinical Research in Urology:
The journal publishes original clinical research that advances the understanding and treatment of urological diseases, including prostate cancer, bladder cancer, and renal cell carcinoma. This includes studies on surgical techniques, medical therapies, and the integration of new technologies in clinical practice. - Guidelines and Best Practices:
The journal is a key outlet for the European Association of Urology (EAU) guidelines, providing critical appraisals and updates that help shape clinical practices across Europe and beyond. - Innovative Technologies and Techniques:
Research on novel surgical techniques, robotic surgeries, and minimally invasive procedures is a significant focus, showcasing advancements that improve patient outcomes and reduce complications. - Biomarkers and Genomics:
The journal highlights studies on biomarkers in urology, particularly those related to cancer diagnosis, prognosis, and treatment response, including genetic and epigenetic factors influencing urological cancers. - Patient-Centered Research:
A growing emphasis on patient-reported outcomes, quality of life assessments, and the psychological aspects of urological health informs the journal's commitment to holistic patient care. - Translational Research:
Translational studies that bridge basic science and clinical application, including the investigation of immunotherapy and targeted therapies, are essential components of the journal's scope.
Trending and Emerging
- Artificial Intelligence and Digital Health:
The integration of AI in diagnostics, treatment planning, and patient management is rapidly gaining traction, with increasing numbers of studies exploring its potential in urology. - Personalized Medicine:
Research focusing on personalized approaches to treatment based on genetic, biomarker, and individual patient data is on the rise, particularly in the context of prostate and bladder cancer. - Minimally Invasive Techniques:
There is a significant trend towards minimally invasive surgeries, including robotic-assisted procedures and novel techniques that improve patient recovery times and outcomes. - Immunotherapy and Targeted Therapies:
As immunotherapy continues to evolve, research on its application in urological cancers, particularly bladder and renal cell carcinoma, is increasingly prominent in the journal. - Patient-Reported Outcomes and Quality of Life:
A growing body of literature is dedicated to understanding the impact of urological conditions and treatments on patients' quality of life, emphasizing the importance of patient-centered care. - Microbiome Research:
Emerging studies on the role of the urinary microbiome in health and disease are gaining interest, particularly in relation to urinary tract infections and bladder health.
Declining or Waning
- Traditional Open Surgery Techniques:
There is a noticeable decline in publications related to traditional open surgical techniques as robotic and minimally invasive procedures gain preference in clinical practice. - General Urology Topics:
Papers that cover broad, non-specific urology topics are becoming less common, with a shift towards more specialized research that addresses specific diseases or innovative treatments. - Historical Perspectives:
Although historical analyses have their value, the journal has seen a reduction in articles that focus on historical perspectives of urology, likely due to the increasing demand for cutting-edge research and clinical advancements. - Non-Evidence Based Practices:
There is a growing emphasis on evidence-based practices, leading to a decline in articles that do not clearly demonstrate clinical efficacy or are based on anecdotal evidence.
Similar Journals
Research and Reports in Urology
Pioneering clinical insights in the world of urology.Research and Reports in Urology, published by DOVE MEDICAL PRESS LTD, is a premier journal dedicated to the dissemination of cutting-edge research and clinical advancements in the field of urology. With an impressive impact factor and a recognized status as Q2 within the urology category, this journal offers a vital platform for researchers, practitioners, and students eager to engage with the latest findings and methodologies. Since its inception in 2009, the journal has embraced an Open Access model, ensuring that critical research is freely available to the global community, thereby fostering collaboration and innovation in urological science. Based in New Zealand, it operates within a robust international framework, allowing for a diverse range of contributions that address pressing issues in urology and enhance professional knowledge. Researchers are encouraged to submit their work and become part of this influential discourse, as the journal continues to navigate the rapidly evolving landscape of urological health from 2012 to 2024 and beyond.
Journal of Pediatric Urology
Empowering the future of children's health with cutting-edge insights.Journal of Pediatric Urology is a leading academic journal dedicated to the intersection of pediatric medicine and urological science. Published by ELSEVIER SCI LTD, this esteemed journal provides a vital platform for the dissemination of innovative research and clinical advancements in the field. With a 2023 impact factor that places it within the Q2 quartile for Pediatrics, Perinatology and Child Health, and the Q1 quartile for Urology, it is recognized among the top-tier journals in both domains. The journal covers a broad spectrum of topics from minimally invasive surgical techniques to management strategies for congenital urological disorders. This makes it an invaluable resource for researchers, clinicians, and students who seek to improve pediatric urological care. As the journal continues to evolve, it aims to foster interdisciplinary collaboration that drives further advancements in pediatric health. For those looking to avoid publication barriers, the journal retains traditional access options while contributing to the global growth of pediatric urology research from its base in the Netherlands.
Turkish Journal of Urology
Elevating Research, Empowering PracticeTurkish Journal of Urology, published by AVES, is a distinguished academic journal dedicated to the field of urology. As an open-access journal since 2022, it aims to disseminate high-quality research findings, clinical studies, and reviews that contribute to the advancement of urological science and practice. With a notable presence in the academic community, the journal currently holds a Scopus rank of #59 out of 107 in the Medicine _ Urology category, placing it in the 45th percentile. This positions the Turkish Journal of Urology as a vital resource for researchers, healthcare professionals, and students seeking to stay informed on the latest developments and innovations in urology. Publishing from its base in Istanbul, Turkiye, the journal emphasizes accessibility and visibility, making it a powerful platform for scholarly communication in an increasingly globalized field.
Current Urology
Bridging Theory and Practice in Urology and BeyondCurrent Urology, published by Lippincott Williams & Wilkins, is a leading journal dedicated to advancing the fields of urology, oncology, and reproductive medicine. With an ISSN of 1661-7649 and E-ISSN of 1661-7657, this journal has established itself as a valuable resource for researchers, practitioners, and students alike, providing peer-reviewed articles that contribute to the ongoing discourse and development of these critical specialties. Operating out of the United States, Current Urology ranks in the third quartile for oncology, reproductive medicine, and urology, reflecting its importance in the medical community. The journal’s focus on innovative research and clinical practice allows it to bridge gaps between theoretical understanding and practical application, enhancing patient care and outcomes. Although currently not an open-access journal, it offers a wealth of insights and findings that underpin contemporary urological practices and research. In an evolving medical landscape, Current Urology remains an essential platform for disseminating knowledge and fostering collaboration among experts in the field.
International Braz J Urol
Fostering Collaboration for Urological ExcellenceInternational Brazilian Journal of Urology, published by the Brazilian Society of Urology, is a distinguished open-access journal that has been contributing to the field of urology since 2003. This journal plays a vital role in disseminating high-quality research and advancements in various aspects of urological science and medicine, targeting an international audience of researchers, practitioners, and students. With an impressive ranking in the 2023 Scopus metrics, securing Q2 status in both Medicine (Miscellaneous) and Urology, it stands as a significant resource for emerging trends and discoveries in these areas. The journal’s commitment to accessibility, with open access since its inception, ensures that valuable findings are readily available to the global medical community. Situated in Rio de Janeiro, Brazil, the International Brazilian Journal of Urology not only enhances academic discourse but also fosters collaboration across borders and specialties, making it a pivotal platform for advancing urological research.
CUAJ-Canadian Urological Association Journal
Shaping the Future of Urology with Rigorous Research.CUAJ - Canadian Urological Association Journal is a premier, peer-reviewed journal dedicated to advancing the field of urology, published by the Canadian Urological Association. With its ISSN 1911-6470 and E-ISSN 1920-1214, the journal serves as a vital platform for disseminating high-quality research and clinical insights relevant to urology and oncology. Located in Canada, CUAJ is committed to publishing original research, reviews, and case studies that contribute to the scientific community's understanding of urological diseases and treatments. As of 2023, CUAJ holds a notable ranking of Q2 in Urology and Q3 in Oncology, reflecting its rigorous editorial standards and impactful contributions to the field, particularly acknowledged by its Scopus ranking as #61 in the Medicine and Urology category. Although primarily not an open-access journal, it aims to foster scholarly communication that empowers researchers, healthcare professionals, and students. With a rich history from its inception in 2007, CUAJ continues to play an integral role in shaping urological education and practice, making it an essential read for anyone involved in this dynamic field.
BJU INTERNATIONAL
Advancing Urological Science with ImpactBJU International is a prestigious academic journal specializing in the field of Urology, published by WILEY, one of the leading publishers in scientific literature. With an impressive impact factor and recognized as a Q1 journal in Urology for 2023, it ranks #7 out of 120 in the Scopus Medicine _ Urology category, placing it in the 94th percentile among its peers. Established in 1929 and with converged years from 1994 to 2024, BJU International provides a platform for groundbreaking research, clinical studies, and advancements in urological science. The journal is accessible in both print and online formats, catering to a global audience dedicated to enhancing urological practice and research. By fostering interdisciplinary dialogue and disseminating high-quality studies, BJU International plays a crucial role in advancing knowledge and improving patient care in the field of urology.
Bladder Cancer
Connecting clinicians and scholars in the fight against bladder cancer.Bladder Cancer, published by IOS PRESS, is a premier open access journal dedicated to advancing the field of oncology and urology, with a specific focus on bladder cancer research and treatment. Established in 2015 and continuing through to 2024, this journal aims to disseminate high-quality, peer-reviewed research that contributes to the understanding, diagnosis, and management of bladder cancer, a critical area of concern in urological oncology. With a robust publication record now encompassing open access since 2023, Bladder Cancer ensures accessibility to vital research for clinicians, researchers, and scholars worldwide. The journal's rankings in Scopus reflect its commitment to excellence, holding a Q3 category in both oncology and urology, with Scopus ranks of #78 in Urology and #285 in Oncology, showcasing its growing influence in the scientific community. By fostering dialogue and innovation, Bladder Cancer serves as an essential resource for those committed to improving patient outcomes in bladder oncology.
African Journal of Urology
Fostering Collaboration for Healthier FuturesAfrican Journal of Urology (ISSN: 1110-5704, E-ISSN: 1961-9987) is a leading scholarly publication in the field of urology, published by SPRINGER from the United Kingdom. Since adopting an open access model in 2012, this journal has aimed to increase the visibility and dissemination of vital research findings across the African continent and beyond. With a current impact factor and significant standing, as denoted by its Q3 ranking in Urology for 2023, it serves as an essential platform for clinicians, researchers, and students alike. The journal's scope encapsulates all aspects of urology, fostering advancements in both clinical practices and innovative research while specifically addressing healthcare challenges relevant to African populations. As part of its commitment to accessibility and academic excellence, the journal offers full open access to its content, allowing for a broad readership and engagement with cutting-edge studies. Engage with the African Journal of Urology to contribute to and stay informed about vital developments in urological science.
UROLOGY
Advancing Urological Knowledge for Tomorrow's CareUROLOGY is a prestigious journal published by Elsevier Science Inc, renowned for disseminating high-quality research and reviews in the field of urology. With an ISSN of 0090-4295 and E-ISSN 1527-9995, this journal has been a trusted resource since its inception in 1973 and continues to provide insights into the latest advancements and clinical practices in urology, maintaining a category quartile of Q2 as of 2023. The journal ranks 50th out of 120 in the Scopus metrics for Medicine - Urology, placing it in the 58th percentile, which underscores its influence and relevance in the academic community. Although it is not structured as an open access journal, it offers a wealth of knowledge vital for researchers, healthcare professionals, and students alike, enabling them to stay abreast of evolving treatments and innovations in the field. As we move towards 2024, UROLOGY remains committed to advancing research and enhancing practices in urological care, fostering a collaborative environment among its readership.